• Share
  • Email
  • Print
Get Connected COVID-19EventsSign-UpBlogsRSS

K&L Gates Advises Knopp Neurosciences on $345 Million License Agreement for Lou Gehrig’s Disease Drug Candidate

August 19, 2010